Dr. Ray O’Connor explores the latest updates on Cardiovascular Disease (CVD) management in clinical research. The European Society of Cardiology has updated its guidelines on managing high blood pressure, emphasizing the continuous risk of CVD related to blood pressure levels. Lower blood pressure targets are recommended in patients with type 2 diabetes. The American Heart Association and American Stroke Association now advocate lifelong access to primary care for stroke prevention. Trials have shown promising results for single-pill combinations of low-dose BP-lowering drugs. Proper arm position during BP measurements is crucial to avoid overestimation of readings. Additionally, COVID-19 vaccine doses have shown to reduce the incidence of arterial and venous thrombotic events.
Source link
You might be interested in…Cardiovascular Disease
